InvestorsHub Logo

Guy

Followers 63
Posts 2553
Boards Moderated 1
Alias Born 05/17/2001

Guy

Member Level

Re: None

Monday, 08/01/2005 9:27:21 AM

Monday, August 01, 2005 9:27:21 AM

Post# of 173917
VPHM - Lazard Freres initiated coverage on Viropharma Incorporated (Nasdaq: VPHM) with a Buy rating; $15.00 price target. The firm expects robust Vancocin sales trends to continue.



A QUITTER NEVER WINS AND A WINNER NEVER QUITS.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.